Join the CEO and immediate past chair of the Certification Board for Diabetes Care and Education for an action-oriented way for preparing for or renewing your certified diabetes care and education specialist (CDCES) status. An expert interdisciplinary panel will be present to provide insight into their experiences as CDCESs, engage with the audience to answer your questions about the process, and provide insight on the influence of the certification on their respective careers
SPONSORED BY AOTI This presentation will first summarize the growing burden that DFUs impose on patients, caregivers, clinicians, and healthcare systems alike, as well as highlight how low-socioeconomic and racial minorities are disproportionally affected. The extensive body of RCT, RWE, Systematic Reviews and Meta Analyses supporting AOTI’s unique cyclical-pressurized Topical Wound Oxygen (TWO2) therapy will be reviewed, which provided the scientific basis for the recent evidence based “A“ grade adjunctive treatment recommendation. The application of TWO2 therapy will be demonstrated as to how it more sustainably heals DFUs and provides patients with more ulcer free days, resulting in significantly less hospitalizations and lower extremity amputations. The effect that TWO2 has, as a patient applied at-home therapy, on improving Access to Care and Health Equity, will also be explored. MIKE GRIFFITHS DPROF, DMS, CRT, FRSM, FCMI [https://ada.digitellinc.com/ada/live/24/page/175] Dr. Griffiths is a seasoned medical device executive who has been the CEO, Medical Director and Co-Founder of AOTI Inc. since 2006. Dr. Griffiths is a Fellow of both the Royal Society of Medicine and Chartered Management Institute. He holds a Doctorate in Medical Device Innovation and Entrepreneurship from Middlesex University, London, United Kingdom, a post-graduate Diploma in Management from Kingston University, United Kingdom, and several further engineering and clinical credentials, including that of a Certified Respiratory Therapist. Dr. Griffiths posses over 35 years of wound and critical care experience gained from a wide variety of roles throughout the globe, working with both start-ups and multinationals alike. Prior to starting AOTI, he was the co-founder and CEO of eVent Medical Ltd., a start-up venture in the critical care ventilation field, which was sold to the Kobayashi pharmaceutical company of Japan. Preceding eVent, Dr. Griffiths held various senior management positions at Mallinckrodt Inc., Nellcor Puritan Bennett Inc., and Hudson RCI, amongst others. Dr. Griffiths is also an active advocate in reducing stigma and achieving mental health equity as the Chairman of the International Bipolar Foundation. ------------------------- CONTACT INFORMATION: Amy Gray, RN, BSN, CWS Assoc. Director of Clinical Development Mobile: (423) 408-3822 Office: (760) 431-4700 Fax: (760) 683-3063 Email: email@example.com Website: www.aotinc.net
Welcome to the Clinical Update Conference
Dr. Nuha El Sayed will deliver an interactive session highlighting key recommendations and updates from the “hot of the press” Standards of Medical Care in Diabetes—2023 (Standards of Care). This is your opportunity to hear the most up-to-date evidence and recommendations from the Standards of Care and have your questions answered by Dr. El Sayed, the ADA’s vice president of Health Care Improvement, and Dr. Robert Gabbay, the ADA’s chief scientific and medical officer.
Dr. Richard Beaser will provide updates in insulin therapies and their use in diabetes clinical care across the lifespan. He will utilize a storytelling, case-based approach to interact with the audience and share his rich experience in the field of diabetes care and education.
Dr. Josh Neumiller will lead an interactive discussion regarding non-insulin therapy updates based on relevant research and the Standards of Medical Care in Diabetes while optimizing clinical decision-making strategies. His case-based approach will emphasize the importance of self-management education to optimize patient use of various non-insulin diabetes pharmacologic therapies.
Dr. Rodica Pop-Busui will review Heart Failure: An Underappreciated Complication of Diabetes: A Consensus Report of the American Diabetes Association and provide the audience with the authors’ insight, including updates to screening, treatment, and education for people with diabetes and heart failure.
Dr. Jane K. Dickinson will share updated research relative to the emotional side of diabetes messages. The discussion will highlight accepting the person with diabetes where they are by leveraging her experience on the topic in diabetes care and education. This is your opportunity to explore the role of context in the diabetes experience; the effect of language in diabetes care, social media, and diabetes education; and the impact on diabetes outcomes.
Hope for Tomorrow (Call to Action)
Over the past 10 years, Ted Kyle has dedicated his career to understanding how to address health issues and needs created by obesity. He will share strategies to stifle the blame and shame that so commonly gets in the way of improving the health of people living with obesity. Mr. Kyle will leverage his experience in collaborating with leading health and obesity experts for sound policy and innovation to address health needs and the obesity epidemic.